Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Visual field constriction in children treated with vigabatrin.

Literature DB >> 10331710

Visual field constriction in children treated with vigabatrin.

S Vanhatalo¹, L Pääkkönen, I Nousiainen.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1999 PMID： 10331710 DOI： 10.1212/wnl.52.8.1713

Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. Vigabatrin associated retinal dysfunction in children with epilepsy.

Authors: R Koul; A Chacko; A Ganesh; S Bulusu; K Al Riyami
Journal: Arch Dis Child Date: 2001-12 Impact factor: 3.791

Review 2. Vigabatrin.

Authors: James W Wheless; R Eugene Ramsay; Stephen D Collins
Journal: Neurotherapeutics Date: 2007-01 Impact factor: 7.620

3. Visual field constriction and electrophysiological changes associated with vigabatrin.

Authors: Dorothea Besch; Anne Kurtenbach; Eckart Apfelstedt-Sylla; Bettina Sadowski; Dieter Dennig; Christiane Asenbauer; Eberhart Zrenner; Ulrich Schiefer
Journal: Doc Ophthalmol Date: 2002-03 Impact factor: 2.379

4. Modelling the topography of absolute defects in patients exposed to the anti-epileptic drug vigabatrin and in normal subjects using automated static suprathreshold perimetry of the entire 80° visual field.

Authors: Dorothea Besch; Ulrich Schiefer; Nicole Eter; Roland Burth; Christian E Elger; Manfred Spitznas; Klaus Dietz
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2011-03-05 Impact factor: 3.117

Visual field constriction in children treated with vigabatrin.

1. Vigabatrin associated retinal dysfunction in children with epilepsy.

Review 2. Vigabatrin.

3. Visual field constriction and electrophysiological changes associated with vigabatrin.

4. Modelling the topography of absolute defects in patients exposed to the anti-epileptic drug vigabatrin and in normal subjects using automated static suprathreshold perimetry of the entire 80° visual field.

Review 5. The safety and tolerability of newer antiepileptic drugs in children and adolescents.

6. Visual field defects in pediatric patients on vigabatrin monotherapy.

7. Vigabatrin and visual field defects in pediatric epilepsy patients.

Review 8. Treatment of partial seizures in childhood : an overview.

Review 9. Modeling epileptic spasms during infancy: Are we heading for the treatment yet?

Review 10. Behavioural effects of the new anticonvulsants.